Reset Map6 Results
B260 Meditrina Babraham Research Campus Cambridge, Cambridge, CB22 3AT United KingdomBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
Charnock Bradley Building Easter Bush, Roslin, Midlothian EH25 9RG, UK Midlothian, Midlothian, EH25 9RG United KingdomBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
147 Alhambra Circle Suite 220 Coral Gables, Florida, 33134 United StatesBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
The Science Village, Chesterford Research Park United Kingdom Cambridge, Cambridgeshire, CB10 1XL United KingdomBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
Little Chesterford, England, CB10 1XL United KingdomBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
200 Westboro Road 201 Westboro Road Grafton, MA, 01536 United StatesBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.